Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.

Tansarli GS, Papaparaskevas J, Balaska M, Samarkos M, Pantazatou A, Markogiannakis A, Mantzourani M, Polonyfi K, Daikos GL.

Int J Antimicrob Agents. 2018 Sep;52(3):397-403. doi: 10.1016/j.ijantimicag.2018.06.012. Epub 2018 Jun 28.

PMID:
29960007
2.

Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.

Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL.

Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Review.

PMID:
28356041
3.

Wireless electrostimulation: a new approach in combating infection?

Kambouris ME, Markogiannakis A, Arabatzis M, Manoussopoulos Y, Kantzanou M, Velegraki A.

Future Microbiol. 2017 Mar;12:255-265. doi: 10.2217/fmb-2017-0157. Epub 2017 Feb 20.

PMID:
28262048
4.

Treating infections caused by carbapenemase-producing Enterobacteriaceae.

Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL.

Clin Microbiol Infect. 2014 Sep;20(9):862-72. doi: 10.1111/1469-0691.12697. Epub 2014 Jul 12. Review.

5.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.

Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, Georgiadou S, Markogiannakis A, Goukos D, Skoutelis A.

Antimicrob Agents Chemother. 2014;58(4):2322-8. doi: 10.1128/AAC.02166-13. Epub 2014 Feb 10.

6.

Confronting carbapenemase-producing Klebsiella pneumoniae.

Markogiannakis A, Tzouvelekis LS, Psichogiou M, Petinaki E, Daikos GL.

Future Microbiol. 2013 Sep;8(9):1147-61. doi: 10.2217/fmb.13.71. Review.

PMID:
24020742
7.

Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns.

Kosmidis C, Giannopoulou M, Flountzi A, Markogiannakis A, Goukos D, Petrikkos G, Daikos GL, Tzanetou K.

J Chemother. 2013 Aug;25(4):217-21. doi: 10.1179/1973947813Y.0000000073.

PMID:
23906075
8.

Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.

Daikos GL, Markogiannakis A, Souli M, Tzouvelekis LS.

Expert Rev Anti Infect Ther. 2012 Dec;10(12):1393-404. doi: 10.1586/eri.12.138. Review.

PMID:
23253318
9.

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL.

Clin Microbiol Rev. 2012 Oct;25(4):682-707. doi: 10.1128/CMR.05035-11. Review.

10.

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Daikos GL, Markogiannakis A.

Clin Microbiol Infect. 2011 Aug;17(8):1135-41. doi: 10.1111/j.1469-0691.2011.03553.x. Epub 2011 Jun 2. Review.

11.

Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.

Skiada A, Markogiannakis A, Plachouras D, Daikos GL.

Int J Antimicrob Agents. 2011 Mar;37(3):187-93. doi: 10.1016/j.ijantimicag.2010.11.019. Epub 2011 Feb 4. Review.

PMID:
21295448
12.

Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use.

Daikos GL, Skiada A, Pavleas J, Vafiadi C, Salatas K, Tofas P, Tzanetou K, Markogiannakis A, Thomopoulos G, Vafiadi I, Petrikkos G.

J Chemother. 2010 Jun;22(3):175-8.

PMID:
20566422
13.

Multidrug-resistant Klebsiella pneumoniae mediastinitis safely and effectively treated with prolonged administration of tigecycline.

Evagelopoulou P, Myrianthefs P, Markogiannakis A, Baltopoulos G, Tsakris A.

Clin Infect Dis. 2008 Jun 15;46(12):1932-3. doi: 10.1086/588557. No abstract available.

PMID:
18540810
14.

Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.

Markogiannakis A, Fildisis G, Tsiplakou S, Ikonomidis A, Koutsoukou A, Pournaras S, Manolis EN, Baltopoulos G, Tsakris A.

Infect Control Hosp Epidemiol. 2008 May;29(5):410-7. doi: 10.1086/533545.

PMID:
18419362
15.

Bronchial stump buttressing with an intercostal muscle flap in diabetic patients.

Sfyridis PG, Kapetanakis EI, Baltayiannis NE, Bolanos NV, Anagnostopoulos DS, Markogiannakis A, Chatzimichalis A.

Ann Thorac Surg. 2007 Sep;84(3):967-71.

PMID:
17720409
16.

Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.

Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A.

Int J Antimicrob Agents. 2007 Jan;29(1):34-8. Erratum in: Int J Antimicrob Agents. 2007 Sep;30(3):287. Papapareskevas Joseph [corrected to Papaparaskevas, Joseph].

PMID:
17189092
17.

Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.

Pournaras S, Ikonomidis A, Markogiannakis A, Spanakis N, Maniatis AN, Tsakris A.

J Med Microbiol. 2007 Jan;56(Pt 1):66-70.

PMID:
17172519
18.

The influence of local instillation of fusidic acid on the development of microbial complications after lung resection.

Baltayiannis N, Markogiannakis A, Sfyridis P, Manolis EN, Anagnostopoulos D, Bolanos N, Hatzimichalis A, Tsakris A.

J Chemother. 2006 Jun;18(3):285-92.

PMID:
17129839
19.

Low genetic diversity of the intrinsic OXA-51-like class D carbapenemases among Acinetobacter baumannii clinical isolates in Greece.

Ikonomidis A, Pournaras S, Markogiannakis A, Maniatis AN, Manolis EN, Tsakris A.

Epidemiol Infect. 2007 Jul;135(5):877-81. Epub 2006 Nov 17.

20.

Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.

Tsakris A, Ikonomidis A, Pournaras S, Spanakis N, Markogiannakis A.

J Antimicrob Chemother. 2006 Nov;58(5):1097-9. Epub 2006 Sep 22. No abstract available.

PMID:
16997843
21.

Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece.

Tseliou PM, Spanakis N, Spiliotakara A, Markogiannakis A, Legakis NJ, Tsakris A.

Int J STD AIDS. 2006 Aug;17(8):543-6.

PMID:
16925902
22.

In vivo effect of carbon dioxide laser-skin resurfacing and mechanical abrasion on the skin's microbial flora in an animal model.

Manolis EN, Tsakris A, Kaklamanos I, Markogiannakis A, Siomos K.

Dermatol Surg. 2006 Mar;32(3):359-64.

PMID:
16640679
23.

Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseases.

Petrikkos G, Kastanakis M, Markogiannakis A, Kastanakis S, Bastounis E, Antonios P, Daikos GL, Katsilambros N.

Int J Antimicrob Agents. 2006 Apr;27(4):331-4. Epub 2006 Mar 24.

PMID:
16563705
24.

Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.

Pournaras S, Tsakris A, Ikonomidis A, Markogiannakis A, Kristo I, Maniatis AN.

Scand J Infect Dis. 2006;38(3):213-6.

PMID:
16500785
25.

Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.

Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ, Tsakris A.

J Antimicrob Chemother. 2006 Mar;57(3):557-61. Epub 2006 Jan 23.

PMID:
16431857
26.

VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe.

Sofianou D, Markogiannakis A, Metzidie E, Pournaras S, Tsakris A.

Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):854-5. No abstract available.

PMID:
16333608
27.

Heteroresistance to carbapenems in Acinetobacter baumannii.

Pournaras S, Ikonomidis A, Markogiannakis A, Maniatis AN, Tsakris A.

J Antimicrob Chemother. 2005 Jun;55(6):1055-6. Epub 2005 Apr 11. No abstract available.

PMID:
15824088
28.

Evolution of antibiotic resistance of non-typhoidal salmonellae in Greece during 1990-97.

Velonakis EN, Markogiannakis A, Kondili L, Varjioti E, Mahera Z, Dedouli E, Karaitianou A, Vakalis N, Bethimouti K.

Euro Surveill. 2001 Jul;6(7):117-20.

PMID:
12631956
29.

Outbreak of Salmonella gastroenteritis among attendees of a restaurant opening in Grece, June 1998.

Hadjichristodoulou C, Nikolakopoulou E, Karabinis K, Karakou E, Markogiannakis A, Panoulis C, Lampiri M, Tassios P.

Euro Surveill. 1999 Jun;4(6):72-75.

PMID:
12631900
30.

Epidemiology of antibiotic resistance of human nontyphoidal salmonellae in Greece during an 8-year period (1990-1997).

Velonakis EN, Markogiannakis A, Kondili L, Varjioti E, Skarmoutsou A, Gypari C, Ktenas E, Karaitianou A, Bethimouti K.

Eur J Epidemiol. 2001;17(8):751-5.

PMID:
12086093
31.

Evolution of antibiotic resistance of non-typhoidal salmonellae in Greece during 1990-97.

Velonakis EN, Markogiannakis A, Kondili L, Varjioti E, Mahera Z, Dedouli E, Karaitianou A, Vakalis N, Bethimouti K.

Euro Surveill. 2001 Jul-Aug;6(8):117-20.

PMID:
11673638
32.

Multiple clones within multidrug-resistant Salmonella enterica serotype Typhimurium phage type DT104. The Greek Nontyphoidal Salmonella Study Group.

Markogiannakis A, Tassios PT, Lambiri M, Ward LR, Kourea-Kremastinou J, Legakis NJ, Vatopoulos AC.

J Clin Microbiol. 2000 Mar;38(3):1269-71.

33.

Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.

Gazouli M, Tzelepi E, Markogiannakis A, Legakis NJ, Tzouvelekis LS.

FEMS Microbiol Lett. 1998 Aug 15;165(2):289-93.

34.

Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.

Tzouvelekis LS, Gazouli M, Markogiannakis A, Paraskaki E, Legakis NJ, Tzelepi E.

J Antimicrob Chemother. 1998 Aug;42(2):273-5. No abstract available.

PMID:
9738854
35.

Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece.

Tassios PT, Markogiannakis A, Vatopoulos AC, Katsanikou E, Velonakis EN, Kourea-Kremastinou J, Legakis NJ.

J Clin Microbiol. 1997 Jun;35(6):1316-21.

Supplemental Content

Loading ...
Support Center